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Abstract
Background:  Explore the interaction between apolipoprotein E (Apo E), phospholipase A2
(PLA2) and β2 adrenergic receptor (β2-AR) gene polymorphisms and lipid profiles in an elderly
Chinese population.
Methods: Five hundred subjects aged 65 to 74 years were randomly selected from a community
i n  s o u t h e r n  T a i w a n  t o  a s s e s s  t h e  r e lationship between Apo E, PLA2 and β2-AR gene
polymorphisms and lipid profiles. Two hundred sixty-seven participants agreed to have venous
blood drawn for DNA studies.
Results: Two statistically significant differences were noted in TC and LDL-C in the Gln27Glu of
the β2-AR gene polymorphism (P = 0.007, P = 0.022). The low-income group had a higher HDL-C
level (p = 0.076). The Gln27Glu polymorphism Glu/Glu or Gln/Glu subjects had lower TC levels
compared to the Gln27Glu polymorphism Gln/Gln subjects (p = 0.092).     Lower TC levels (p =
0.082) and lower LDL-C levels (p = 0.045) in subjects with the Cys19Arg16Glu27 haplotype. Lower
TC levels (p = 0.06) were also noted in subjects with the Cys19Gly 16Glu27 haplotype. On the other
hand, higher VLDL-C levels (p = 0.185) and higher triglyceride (TG) levels (p = 0.190) were noted
in subjects with the Cys19Gly 16Gln27 haplotype. The ε2 allele combined with low income had a
positive effect on HDL-C (p = 0.0011), after adding the income factor in this study.
Conclusion: When the effects of Apo E and PLA2 on lipid profiles were included in this study, β2-
AR gene polymorphisms reduced significant effect on lipid profiles. Similarly, low income increased
effect on HDL-C. This study appeared that the results of gene-gene and gene-environment
interaction, it should be considered in further studies for lipid profiles.
Background
In a previous study, endogenous catecholamines were
involved in the regulation of adipose tissue lipolysis, non-
esterified fatty acid distribution, lipoprotein metabolism,
obesity, glucose homeostasis, diabetes mellitus, blood
pressure and metabolic syndrome [1]. Metabolic syn-
drome was defined as abdominal obesity, hyperglycemia,
hypertension, hypertriglyceridemia and low high-density
lipoprotein cholesterol (HDL-C). Adrenergic receptors
(ARs) can regulate lipid mobilization, energy expenditure
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and glycogen breakdown through these endogenous cate-
cholamines [1]. Catecholamines have been found to act
through both β- and α-adrenergic receptors, which medi-
ate their effects through different receptor pathways.
Besides, many studies have demonstrated associations
between β2 adrenergic receptor (β2-AR) gene polymor-
phisms and various diseases: obesity, type 2 diabetes
(T2DM) [2], metabolic syndrome, metabolic disorders
[3,4] and hypertension [5,6]. Therefore, the β2-AR gene
may constitute a potential candidate gene to explain part
of the genetic predisposition to human obesity and
related traits.
Yang-Feng et al. reported that human β2-AR gene poly-
morphisms were located on the distal portion of the long
arm of chromosome 5 (5q32-q34) [7]. Several polymor-
phisms have been found in the coding region of the β2-AR
gene (Gly16Arg, Gln27Glu and Thr164Ile) and in the pro-
moter region (5'LC-Cys19Arg), each of them leading to
amino-acid substitution [8]. In their studies, Dallon-
geville et al. found that the Gly16Arg and Gln27Glu vari-
ants of the β2-AR gene contribute to metabolic syndrome
susceptibility in men [4] Large et al. found that the
Gln27Glu polymorphism of the β2-AR gene was mark-
edly associated with obesity with a relatively higher risk
for obesity and an odds ratio of approximately 10 [9]. The
5'LC-Cys19Arg protein modulates receptor translation
[10], and Gly16Arg and Gln27Glu alterations of cellular
trafficking and receptor desensitization [11-13] were
found. Furthermore, another study [14] showed a signifi-
cant association between the three polymorphisms of the
β2-AR gene, 5'LC-Cys19Arg, Gly16Arg and Gln27Glu,
and triglyceride (TG) and low-density lipoprotein choles-
terol (LDL-C) plasma levels. So we hypothesized that the
associations of these three single nucleotide polymor-
phisms (SNPs): 5'LC-Cys19Arg, Gly16Arg and Gln27Glu,
and haplotypes of the β2-AR gene with lipid profiles,
would be present in our study. In light of these consider-
ations, we conducted a study in an ethnic Chinese elderly
population to investigate the role of the three polymor-
phisms, 5'LC-Cys19Arg, Gly16Arg and Gln27Glu, of the
β2-AR gene and related haplotypes in lipid profiles in eld-
erly subjects.
The relationship between elevated serum total cholesterol
(TC) and LDL-C concentrations, low HDL-C concentra-
tions, and coronary heart disease in middle age [15-18]
and early old age has been established [19]. In a past study
[20], we established a possible module map among apol-
ipoprotein E (Apo E), phospholipase A2 (PLA2) polymor-
phism, and lipid profiles in an elderly ethnic Chinese
population. The presence of a physiologic balance con-
tributed significantly to homeostasis and compensatory
responses regulation of blood HDL-C and LDL-C profiles.
In other past studies [21,22], we found the protective
effect of the APoε2 allele against Alzheimer's disease and
the higher risk of Alzheimer's disease in subjects with the
APoε4 allele. And in another study [23], β-blockers were
found to worsen delayed memory function in people with
cognitive impairment, and adrenergic signaling was
important for the retrieval of intermediate-term contex-
tual and spatial memories. Furthermore, we thought that
ApoE, PLA2 and β2-AR might all affect the lipid profiles
and have interactions with each other, and associations
with the causes of Alzheimer's disease. This study aimed
to further explore the interactions between ApoE, PLA2
and β2-AR gene polymorphisms and lipid profiles in an
elderly ethnic Chinese population.
Materials and methods
Participants
Employing a multilevel stratified sampling strategy, we
selected subjects from the official household records of an
entire prefecture in southern Taiwan. Three hierarchical
household classifications below the county level were
sequentially randomly sampled. A total of 500 healthy
subjects without major medical diseases and mental ill-
ness aged older than 65 years was recruited for this study.
There were 267 agreed to have venous blood drawn for
DNA extraction for genetic study. In a past study [20], we
explored the associations between ApoE, PLA2 and lipid
profiles in these subjects. Informed consent was obtained,
and the surveys were conducted by trained nurses.
Data Collection and Laboratory Methods
All personal information was obtained during face-to-face
interviews. Blood samples were obtained on the morning
following a 12-hour fast. Cholesterol and triglyceride lev-
els were determined in plasma, and lipoproteins by enzy-
matic methods. LDL-C was calculated using the equation
of Friedewald et al. [24], and very-low-density lipoprotein
cholesterol (VLDL-C) was derived from total cholesterol
(TC) after subtracting LDL-C and HDL-C.
We characterized one SNP in the promoter region (5'LC-
Cys19Arg) and two in the coding region (Gly16Arg and
Gln27Glu) of the β2-AR gene. The missense mutations
5'LC-Cys19Arg, Gly16Arg and Gln27Glu of the β2-AR
gene were genotyped using the flurogenic 5' nuclease
assay application of the ABI PRISM 310 HT Sequence
Detection System (ABI, Foster City, USA). Genotyping of
the 5'LC-Cys19Arg was performed using primers (0.9
mmol/l each) Forward 5'-CCGCTGAATGAGGCTTCCA-3'
and Reverse 5'-CCATGGCGCGCAGTCT-3' and the Taq-
Man MGB probes Fam TCAGCAGGCGGAC and Vic
TCAGCGGGCGGAC. Genotyping of the Gly16Arg was
performed using primers (0.9 mmol/l each) Forward 5'-
GGCAGCGCCTTCTTGCT-3' and Reverse 5'-ACCCACAC-
CTCGTCCCTTT-3' and the MGB probes Fam CCCAAT-
GGAAGCCA and Vic CCCAATAGAAGCCATG.Lipids in Health and Disease 2008, 7:20 http://www.lipidworld.com/content/7/1/20
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Genotyping of the Gln27Glu was performed using prim-
ers (0.9 mmol/l each) Forward 5'-GCGCCGGACCAC-
GAC-3' and Reverse 5'-CCACCACCCACACCTCGT-3' and
the MGB probes Fam TCACGCAGGAAAG and Vic
TCACGCAGCAAAG.
Of the 10 ng/ml stok of DNA, 4 ml were dispensed into
384-well PCR plates using a Biomek FX robot (Beckman
Coulter, Fullerton, USA), to which 6 ml of a mix contain-
ing the primers, MGB probes and TaqMan Universal PCR
Master Mix (ABI, Foster City, CA, USA), were added as per
the manufacturers' instructions. These were sealed with
optical seals (ABI, Foster City, CA, USA) and incubated for
95°C 10 min, followed by 40 cycles of 95°C 15 s and
60°C 1 min before analysis on a 310HT plate reader (ABI,
Foster City, CA, USA).
Statistical Analysis
The outcomes identified were (1) TC; (2) HDL-C; (3)
LDL-C; (4) VLDL-C; and (5) TG levels. Using an analysis
of variance, we compared the average levels of plasma
lipid among the different genotypes. Data were analyzed
using the SPSS version 15.0 for Windows software pack-
age (Chicago, IL, U.S.A.). The unpaired t test was used for
comparison between groups for continuous variables.
Pearson's chi-square test was used for categorical varia-
bles. Hardy-Weinberg equilibrium was tested by means of
gene counting and chi-square analysis. We used multiple
linear regression models to examine the associations of
serum lipids andβ2-AR gene polymorphisms. Analyses
examined the lipid profile as continuous variables. Poten-
tial confounding variables (sex, age, education and
income) were included. In addition, the Jump 5.1 for
Windows software package was used to explore the inter-
active effect among β2-AR, PLA2 and Apo E polymor-
phism, sex, age and income with multivariate regression
analysis for HDL-C and LDL-C. We explored the associa-
tions between haplotypes of theβ2-AR gene and lipid pro-
files by using Unphase Version 3.0 [25] and Phase version
2.1 [26] to code different haplotypes of theβ2-AR gene.
Results
Demographic Characteristics
Of the 500 subjects recruited in this study, 267 agreed to
have venous blood drawn for DNA extraction for genetic
study, yielding a response rate of 53.4%. The comparison
of the socio-demographic characteristics of our respond-
ents with data from the Ministry of the Interior, Taiwan,
revealed that our survey sample did not substantially dif-
fer from the national sample [27]. The mean age was 69.2
years old in the case group (SD = 2.7), compared with
69.3 years old in the control group (SD = 2.8). The differ-
ences in mean age, sex, and monthly income were not sta-
tistically significant between the case and control group (p
> 0.05). The case group included more educated persons
than the control group (p = 0.013). The results are shown
in Table 1.
β2-AR Polymorphisms Genotypes Frequencies
The genotype frequencies of these three polymorphisms:
5'LC-Cys19Arg, Gly16Arg and Gln27Glu of β2-AR gene
were all in Hardy-Weinberg equilibrium in the elderly eth-
nic Chinese population (5'LC-Cys19Arg Genotypes
HWEχ 2 = 03372, Gly16Arg Genotypes HWEχ2 = 0.2135,
Gln27Glu Genotypes HWEχ2 = 0.5541, all < χ2
.95 = 5.99,
χ2 in Hardy-Weinberg equilibrium [χ2
.95 < 5.99, df = 2]).
The genotype frequencies of these three polymorphisms
are shown in Table 2, but the allele frequencies are not
shown. In 5'LC-Cys19Arg polymorphisms, genotype Cys/
Cys appeared most frequently (n = 256, 95.93%), fol-
lowed by Cys/Arg (n = 10, 3.7%), and Arg/Arg (n = 1,
0.4%). In Gly16Arg polymorphisms, genotype Gly/Arg
appeared most frequently (n = 118, 44.2%), followed by
Arg/Arg (n = 85, 31.8%), and Gly/Gly (n = 46, 17.2%); 18
cases were undetectable. In Gln27Glu polymorphisms,
Genotype Gln/Gln appeared most frequently (n = 247,
Table 1: Comparison of Participating and Nonparticipating Subjects
Variable Participants (N = 267) Nonparticipants (N = 233) P* Value
Age (yr) Mean (SDs) 69.18 (2.727) 69.18 (2.832) 0.990
Sex 0.148
Male (%) 157 (58.8) 122 (52.4)
Female (%) 110 (41.2) 111 (47.6)
Education 0.013
Illiterate (%) 117 (43.8) 128 (54.9)
Primary school or above (%) 150 (56.2) 105 (45.1)
Monthly income (USD) 0.107
<$860 (%) 193 (72.3) 190 (81.5)
$860~2,000 (%) 59 (22.1) 33 (14.2)
$2,001~2,860 (%) 12 (4.5) 8 (3.4)
>$2,860 (%) 3 (1.1) 2 (0.9)
*The P values for the percentages of sex, education, and monthly income refer to X2 tests of differences between participating and nonparticipating 
subjects. For age, the P value refers to the t-test of differences between participating and nonparticipating subjects.Lipids in Health and Disease 2008, 7:20 http://www.lipidworld.com/content/7/1/20
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92.5%), followed by Gln/Glu (n = 19, 7.1%), and Glu/
Glu (n = 1, 0.4%).
β2-AR Gene Polymorphisms Association with Plasma Lipid 
Levels
Mean values of the overall plasma lipid levels in the eld-
erly Chinese population across these three β2-AR gene
polymorphism genotypes are shown in Table 2. The only
two statistically significant differences were noted in TC
and LDL-C in Gln27Glu of the β2-AR gene polymorphism
(P = 0.007, P = 0.022). In 5'LC-Cys19Arg of the β2-AR
gene polymorphism, Genotype Arg/Arg subjects had
higher TC and LDL-C levels, but no statistically significant
difference was noted (P = 0.129, P = 0.138), and only one
subject had Genotype Arg/Arg. In the β2-AR Gly16Arg
gene polymorphism, no significant difference was noted.
Using linear regression coefficients between the plasma
lipid levels, the Gln27Glu polymorphisms of the β2-AR
gene, Apo E and PLA2 genotypes, and other possibly
related factors (e.g., sex, age, education, income) were
summarized, as below (Table 3). Only females had lower
TC levels, compared to males, with a statistically signifi-
cant difference (p = 0.018). Although Gln27Glu polymor-
phisms Genotype Glu/Glu or Gln/Glu subjects had lower
TC levels compared to Gln27Glu polymorphisms Geno-
type Gln/Gln subjects, no statistically significant differ-
ence was noted (p = 0.092). Furthermore, PLA2 A2
subjects had lower TC levels compared to Non-PLA2 A2
subjects, and TC levels trended downward with increased
age, but neither showed a statistically significant differ-
ence (p = 0.057, p = 0.053). In HDL-C, the positive effects
of the ε2 allele and female sex were statistically signifi-
cantly (P = 0.032, p = 0.027). Age, PLA2 A2 allele effect
and Glu effect on Gln27Glu polymorphisms in the β2-AR
gene were not statistically significant. In LDL-C, the nega-
tive effects of the PLA2 A2 allele and age were significant
(p = 0.037, p = 0.039). The ε2 allele effect, the Glu effect
on Gln27Glu polymorphisms in the β2-AR gene, and
female sex were not statistically significant.
Income Associated with Plasma Lipid Levels
The 267 elderly subjects were then divided into two
groups based on income: those with monthly income less
than 860 USD (low income group; 193 subjects) and
those with income of 860 USD or more (high income
group; 74 subjects). We explored the different lipid pro-
files between the high income group and low-income
group. In spite of the lack of statistically significant differ-
ence, the low-income group seemed to have a higher
HDL-C level (standardized coefficient = 0.109, t = 1.781,
p = 0.076, data not shown).
Table 2: β2-AR Genotype Frequencies and Plasma Lipids Among Genetically Unrelated Elderly Ethnic Chinese Individuals
5'LC-Cys19Arg genotypes
Lipid level* Arg/Arg (n = 1) Arg/Cys (n = 10) Cys/Cys (n = 256) P Value†
TC 282.0 200.0 (23.1) 215.15 (40.2) 0.129
HDL-C 47.0 45.3 (12.4) 51.13 (14.1) 0.422
LDL-C 204.0 129.7 (18.8) 137.42 (35.9) 0.138
VLDL-C 31.0 25.0 (10.5) 26.67 (15.4) 0.906
TG 151.0 127.0 (53.9) 133.52 (77.1) 0.940
Gly16Arg genotypes
Lipid level* Arg/Arg (n = 85) Gly/Arg (n = 118) Gly/Gly (n = 46) P Value†
TC 216.47 (40.862) 216.10 (41.5) 209.35 (39.2) 0.770
HDL-C 51.92 (14.588) 50.97 (14.8) 51.22 (12.3) 0.283
LDL-C 139.54 (36.410) 138.03 (34.9) 131.70 (36.5) 0.679
VLDL-C 25.01 (13.626) 27.28 (14.9) 26.43 (18.9) 0.512
TG 125.28 (68.208) 136.82 (74.7) 132.17 (94.4) 0.527
Gln27Glu genotypes
Lipid level* Gln/Gln (n = 247) Gln/Glu (n = 19) Glu/Glu (n = 1) P Value†
TC 216.42 (40.287) 190.63 (35.7) 282.0 0.007
HDL-C 51.20 (14.276) 47.21 (11.1) 47.0 0.475
LDL-C 138.36 (35.378) 121.21 (33.0) 204.0 0.022
VLDL-C 26.95 (15.590) 22.21 (8.8) 31.0 0.410
TG 134.90 (78.011) 112.11 (45.3) 151.0 0.443
*Lipid level: mean (SDs) (mg/dL)
† The P values for all variables refer to F tests of differences between theβ2-AR genotype categories.Lipids in Health and Disease 2008, 7:20 http://www.lipidworld.com/content/7/1/20
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Different Haplotypes of the β2-AR gene Associated with 
Plasma Lipid Levels
Based on the different genotypes of these three polymor-
phisms, 5'LC-Cys19Arg, Gly16Arg and Gln27Glu of the
β2-AR gene, we had different haplotypes of the β2-AR
gene. By using Unphase Version 3.0 analysis, we coded
the different haplotypes of the β2-AR gene, and then
explored the associations between the different haplo-
types and lipid profiles of these elderly subjects. We found
that only the Cys19Arg16Glu27  haplotype and the
Cys19Gly16Glu27 haplotype in subjects had some associa-
tion with lipid profiles. We found lower TC levels (p =
0.082) and lower LDL-C levels (p = 0.045) in subjects
with the Cys19Arg16Glu27 haplotype, and also lower TC
levels (p = 0.06) in subjects with the Cys19Gly 16Glu27 hap-
lotype (Table 4). Only two subjects had the
Cys19Arg16Glu27 haplotype and six subjects, the Cys19Gly
16Glu27 haplotype. We also found higher VLDL-C (P =
0.185) and higher TG levels (P = 0.190) in subjects with
the Cys19Gly  16Gln27  haplotype. However, the above
results did not reach statistical significance.
Using Phase Version 2.1 analysis to define the haplotypes
of all subjects, we found that each subject in this study had
two sequences of haplotypes of the β2-AR gene. We then
divided these elderly subjects into two groups, according
to whether they possessed the Cys19Gly 16Gln27haplotype
or not. We could not find any statistically significant dif-
ference in lipid profiles between these two groups of eld-
erly, using logistic regression analysis.
Discussion
In our study, the ε2 allele and female sex had statistically
significant (p = 0.032, p = 0.027) positive effects on HDL-
C. The low income group also seemed to have higher
HDL-C levels (P = 0.076). In LDL-C, the PLA2 A2 allele
and age had significantly (p = 0.037, p = 0.039) negative
effects. So, we explored the interactive effects among PLA2
and the Apo E polymorphism, sex and income on HDL-C,
using multivariate regression analysis with the Jump 5.1
for Windows software package. We found that the ε2
allele combined with low income had a positive effect on
HDL-C (p = 0.0011). We also found that the A2 allele
combined with the ε2 allele had a positive effect on LDL-
C (p = 0.0002).
In another study [14], Petrone et al. found that 5'LC-Cys19
homozygous showed higher TG and LDL-C levels com-
pared to 5'LC-Arg19 homozygous. A similar increase in TG
and LDL-C levels was observed for the Gly16Arg polymor-
phism and the Gln27Glu polymorphism. And, they
found that the Cys19Arg16Gln27 haplotype determined a
significant increase in TG and LDL-C levels compared to
the Arg19Gly16Glu27 haplotype. After performing the final
parsimonious model of multiple linear regression coeffi-
cients between the plasma lipid levels, the Gln27Glu pol-
ymorphism of the β2-AR gene, Apo E and PLA2
genotypes, and other possibly related factors, the
Gln27Glu polymorphism Glu/Glu or Gln/Glu subjects
had lower TC levels compared to the Gln27Glu polymor-
phism Gln/Gln subjects, but no statistically significant
difference was noted (p = 0.092) (Table 3). And in differ-
ent haplotypes of the β2-AR gene associated with plasma
lipid levels, we found significantly lower TC levels (p =
0.082) and lower LDL-C levels (p = 0.045) in subjects
with the Cys19Arg16Glu27 haplotype, and significant lower
TC levels (p = 0.06) in subjects with the Cys19Gly 16Glu27
haplotype (Table 4). But there were too few subjects with
these two haplotypes. We also found higher VLDL-C lev-
els (p = 0.185) and higher TG levels (p = 0.190) in subjects
with the Cys19Gly 16Gln27 haplotype. Altogether, none of
our results showed a statistically significant difference.
However, we believe that the difference in results between
our study and the study by Petrone et al.15 regarding the
β2-AR gene may be due to the following reasons. Firstly,
their subjects were overweight/obese subjects (body mass
index [BMI] >25 kg/m2), who were consecutively
recruited from the metabolic day hospital of the Depart-
ment of Clinical Sciences of their university. Our subjects
Table 3: The Parsimonious Model for TC, HDL-C and LDL-C
TC HDL-C LDL-C
Variables Coef (S.E.) P Coef (S.E.) P Coef (S.E.) P
ε2allele effect 9.9(13.9) 0.474 11.0(5.1) 0.032 2.2(12.2) 0.860
A2 allele effect -9.6(5.0) 0.057 1.3(1.8) 0.486 -9.3(4.4) 0.037
Glu effect -16.1(9.5) 0.092 -2.9(3.5) 0.401 -8.2(8.4) 0.333
Sex 12.1(5.1) 0.018 4.2(1.9) 0.027 6.3(4.5) 0.164
Age -1.8(0.9) 0.053 0.3(0.3) 0.442 -1.7(0.8) 0.039
ε2allele effect: Apoε2 vs. Non-Apoε2, A2 allele effect: PLA2 A2 vs. Non-PLA2 A2.
Glu effect: Genotype Glu/Glu, Gln/Glu vs. Genotype Gln/Gln in Gln27Glu Genotypes of β2-AR gene. Sex: female vs. male
TC: Total cholesterol; HDL-C: high-density lipoprotein cholesterol; LDL-C: Low-density lipoprotein cholesterol
Coef: Estimate coefficient; S.E.: Standard error; P: P valueLipids in Health and Disease 2008, 7:20 http://www.lipidworld.com/content/7/1/20
Page 6 of 7
(page number not for citation purposes)
were selected from southern Taiwan, and were older than
65 years when they were recruited for this study. The dif-
ference in subjects between their study and our study may
have led to the different results. And we had not let our
subjects to check BMI in our study. So we can not discuss
the impact of BMI on lipid profiles. On the other hand, we
had not use case-control study to evaluate the different
lipid profiles between obesity subjects and control cases.
Secondly, our study had fewer subjects than theirs, and
there were fewer frequencies of some polymorphisms of
the β2-AR gene. The fewer subjects may have led to sub-
jects with fewer of some polymorphisms of the β2-AR
gene, thus leading to different results. In our study, the
lipid profiles of the individual homozygous for the 5'LC-
Arg19 allele and the lipid profile of the individual
homozygous for the Glu27 allele are identical maybe due
to this is the same individual. Thirdly, in their study, they
only defined the frequency of each haplotype, and not the
haplotypes of every subject. In our study, we used Phase
Version 2.1 with Baysin analysis to define the haplotypes
of all subjects to reduce the false positive rate [23].
On the other hand, we were also concerned that epistasis
may present between multiple genes in lipid profiles. The
low income group seemed to have a higher HDL-C level
(p = 0.076) in our study, but in spite of this result not
reaching statistically significant difference, we still wanted
to add the income factor. After adding the income factor
in the study, we found that the ε2 allele combined with
low income had a positive effect on HDL-C (p = 0.0011).
In our past study [20], we also found the opposite effects
of the ε2 allele and the PLA2 A2 allele on HDL-C and LDL-
C. The presence of the ε2 allele with the PLA2 A2 allele
appeared to significantly decrease HDL-C, and the PLA2
A2 allele with the presence of the ε2 allele increased LDL-
C.
Conclusion
We concluded that not only do biological factors like Apo
E, PLA2 and β2-AR affect lipid profiles, but social factors
like income may also affect lipid profiles. We need to
explore more of the effects that can affect lipid profiles to
establish a clearer model to explain the interaction
between genetic factors, social factors, and lipid profiles in
the future. Using the model, if we can find high risk
groups for hyperlipidemia and related disorders like met-
abolic syndrome, diabetes, cardiovascular disease, and
obesity, and adopt adequate solutions, the prevalence of
these disorders may be reduced. On the other hand, we
may also have a clearer understanding of the causes of
Alzheimer's disease using the model.
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Table 4: Plasma Lipids by Different β2-AR Gene Haplotypes 
Among Genetically Unrelated Elderly Chinese Individuals
Lipid level* Non-TGC TGC P Value†
TC 214.69 (41.060) 214.66 (40.298) 0.994
HDL-C 51.11 (14.285) 50.74 (14.044) 0.841
LDL-C 138.64 (36.229) 136.49 (35.255) 0.638
VLDL-C 24.95 (13.279) 27.54 (16.246) 0.185
TG 125.03 (66.570) 137.88 (81.280) 0.190
Lipid level* Non-TGG TGG P Value†
TC 215.38 (39.954) 184.00 (55.328) 0.060
HDL-C 50.98 (14.182) 46.33 (10.013) 0.426
LDL-C 137.68 (35.176) 119.50 (50.087) 0.216
VLDL-C 26.81 (15.377) 18.17 (5.456) 0.171
TG 134.27 (76.960) 90.17 (26.947) 0.163
Lipid level* Non-TAC TAC P Value†
TC 209.82 (39.488) 215.66 (40.715 0.379
HDL-C 51.31 (12.387) 50.78 (14.455) 0.819
LDL-C 132.07 (36.841) 138.33 (35.276) 0.283
VLDL-C 26.44 (19.113) 26.65 (14.416) 0.936
TG 132.22 (95.497) 133.49(72.206) 0.919
Lipid level* Non-TAG TAG P Value†
TC 215.05 (40.399) 165.00 (18.385) 0.082
HDL-C 50.81 (14.138) 59.50 (2.121) 0.386
LDL-C 137.65 (35.377) 87.00 (26.870) 0.045
VLDL-C 26.67 (15.311) 18.50 (6.364) 0.452
TG 133.57 (76.639) 94.50 (36.648) 0.473
Lipid level* Non-CGG CGG P Value†
TC 214.98 (40.812) 207.45 (40.812) 0.547
HDL-C 51.11 (14.171) 45.45 (33.040) 0.194
LDL-C 137.30 (35.870) 136.45 (28.623) 0.939
VLDL-C 26.66 (15.470) 25.55 (10.152) 0.814
TG 133.45 (77.416) 129.18 (51.610) 0.856
*Lipid level: mean (SDs) (mg/dL); † The P values for all variables refer 
to T tests of differences between the two groups.
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